Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS)

Journal of Proteomics

Volumn 75, Issue 2, 2011, Pages 708-717

  Paulo, Joao A ^a,b   Urrutia, Raul ^c   Banks, Peter A ^b   Conwell, Darwin L ^b   Steen, Hanno ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Biomarker; Fibrosis; Pancreatitis; Proteomics; Stellate cells

Indexed keywords

ACTIN; MITOGEN ACTIVATED PROTEIN KINASE 3; RAS PROTEIN; RIBOSOME PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CHRONIC PANCREATITIS; LIQUID CHROMATOGRAPHY; NONHUMAN; PANCREATIC STELLATE CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; TANDEM MASS SPECTROMETRY;

ACTINS; ANIMALS; CELL LINE; CHROMATOGRAPHY, LIQUID; PANCREATIC STELLATE CELLS; PANCREATITIS, CHRONIC; PROTEOMICS; RATS; RIBOSOMAL PROTEINS; TANDEM MASS SPECTROMETRY;

BOVINAE; RATTUS;

EID: 82355190191     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.09.009     Document Type: Article

References (53)

1. Kloppel G., Detlefsen S., Feyerabend B. Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch 2004, 445:1-8.
2. Schneider A., Whitcomb D.C. Hereditary pancreatitis: a model for inflammatory diseases of the pancreas. Best Pract Res Clin Gastroenterol 2002, 16:347-363.
3. Masamune A., Shimosegawa T. Signal transduction in pancreatic stellate cells. J Gastroenterol 2009, 44:249-260.
4. Omary M.B., Lugea A., Lowe A.W., Pandol S.J. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007, 117:50-59.
5. Shimizu K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 2008, 43:823-832.
6. Patel M., Fine D.R. Fibrogenesis in the pancreas after acinar cell injury. Scand J Surg 2005, 94:108-111.
7. Ellenrieder V., Schneiderhan W., Bachem M., Adler G. Fibrogenesis in the pancreas. Rocz Akad Med Bialymst 2004, 49:40-46.
8. Apte M.V., Wilson J.S. Mechanisms of pancreatic fibrosis. Dig Dis 2004, 22:273-279.
9. Masamune A., Kikuta K., Watanabe T., Satoh K., Hirota M., Hamada S., et al. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 2009, 58:550-559.
10. Farrow B., Albo D., Berger D.H. The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res 2008, 149:319-328.
11. Aust S., Jager W., Kirschner H., Klimpfinger M., Thalhammer T. Pancreatic stellate/myofibroblast cells express G-protein-coupled melatonin receptor 1. Wien Med Wochenschr 2008, 158:575-578.
12. Vonlaufen A., Apte M.V., Imhof B.A., Frossard J.L. The role of inflammatory and parenchymal cells in acute pancreatitis. J Pathol 2007, 213:239-248.
13. Mews P., Phillips P., Fahmy R., Korsten M., Pirola R., Wilson J., et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 2002, 50:535-541.
14. Apte M.V., Haber P.S., Darby S.J., Rodgers S.C., McCaughan G.W., Korsten M.A., et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 1999, 44:534-541.
15. Deng X., Liang J., Lin Z.X., Wu F.S., Zhang Y.P., Zhang Z.W. Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis. World J Gastroenterol 2010, 16:1916-1923.
16. Bosselut N., Housset C., Marcelo P., Rey C., Burmester T., Vinh J., et al. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 2010, 10:1017-1028.
17. Molleken C., Sitek B., Henkel C., Poschmann G., Sipos B., Wiese S., et al. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 2009, 49:1257-1266.
18. Kim P.K., Kim M.R., Kim H.J., Yoo H.S., Kim J.S., Cho E.H., et al. Proteome analysis of the rat hepatic stellate cells under high concentrations of glucose. Proteomics 2007, 7:2184-2188.
19. Gressner O.A., Weiskirchen R., Gressner A.M. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 2007, 381:107-113.
20. Kawada N. Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype. Methods Mol Med 2005, 117:371-379.
21. Mathison A., Liebl A., Bharucha J., Mukhopadhyay D., Lomberk G., Shah V., et al. Pancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes. Pancreatology 2010, 10:505-516.
22. Choi H., Fermin D., Nesvizhskii A.I. Significance analysis of spectral count data in label-free shotgun proteomics. Mol Cell Proteomics 2008, 7:2373-2385.
23. Neubauer G., Mann M. Mapping of phosphorylation sites of gel-isolated proteins by nanoelectrospray tandem mass spectrometry: potentials and limitations. Anal Chem 1999, 71:235-242.
24. Steen H., Kuster B., Fernandez M., Pandey A., Mann M. Detection of tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass spectrometry in positive ion mode. Anal Chem 2001, 73:1440-1448.
25. Shilov I.V., Seymour S.L., Patel A.A., Loboda A., Tang W.H., Keating S.P., et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 2007, 6:1638-1655.
26. Dong M.Q., Venable J.D., Au N., Xu T., Park S.K., Cociorva D., et al. Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science 2007, 317:660-663. [New York, NY].
27. Choi H., Nesvizhskii A.I. False discovery rates and related statistical concepts in mass spectrometry-based proteomics. J Proteome Res 2008, 7:47-50.
28. Goodman S.N. Toward evidence-based medical statistics. 1: the P value fallacy. Ann Intern Med 1999, 130:995-1004.
29. Goodman S.N. Toward evidence-based medical statistics. 2: the Bayes factor. Ann Intern Med 1999, 130:1005-1013.
30. Jeffreys H. Theory of probability 1961, Clarendon Press, Oxford. 3d ed.
31. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29.
32. Li D., Li J.Q., Ouyang S.G., Wu S.F., Wang J., Xu X.J., et al. An integrated strategy for functional analysis in large-scale proteomic research by gene ontology. Prog Biochem Biophys 2005, 32:1026-1029.
33. Dong L., Jianqi L., Shuguang O., Songfeng W., Jian W., Yunping Z., et al. An integrated strategy for functional analysis in large scale proteomic research by gene ontology. Mol Cell Proteomics 2005, 4:S34-S.
34. Bairoch A., Apweiler R., Wu C.H., Barker W.C., Boeckmann B., Ferro S., et al. The Universal Protein Resource (UniProt). Nucleic Acids Res 2005, 33:D154-D159.
35. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3.
36. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
37. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
38. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 1999, 27:29-34.
39. Wixon J., Kell D. The Kyoto encyclopedia of genes and genomes-KEGG. Yeast 2000, 17:48-55.
40. Wehr A.Y., Furth E.E., Sangar V., Blair I.A., Yu K.H. Analysis of the human pancreatic stellate cell secreted proteome. Pancreas 2011, 40:557-566.
41. Masamune A., Suzuki N., Kikuta K., Satoh M., Satoh K., Shimosegawa T. Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 2006, 97:1080-1093.
42. Vonlaufen A., Phillips P.A., Yang L., Xu Z., Fiala-Beer E., Zhang X., et al. Isolation of quiescent human pancreatic stellate cells: a promising in vitro tool for studies of human pancreatic stellate cell biology. Pancreatology 2010, 10:434-443.
43. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76:4193-4201.
44. Zybailov B., Mosley A.L., Sardiu M.E., Coleman M.K., Florens L., Washburn M.P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 2006, 5:2339-2347.
45. Zieske L.R. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 2006, 57:1501-1508.
46. Shadforth I.P., Dunkley T.P., Lilley K.S., Bessant C. i-Tracker: for quantitative proteomics using iTRAQ. BMC Genomics 2005, 6:145.
47. Ong S.-E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1:376-386.
48. Molina H., Yang Y., Ruch T., Kim J.W., Mortensen P., Otto T., et al. Temporal profiling of the adipocyte proteome during differentiation using a five-plex SILAC based strategy. J Proteome Res 2009, 8:48-58.
49. Bachem M.G., Schneider E., Gross H., Weidenbach H., Schmid R.M., Menke A., et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432.
50. Dolgin E. The knockout rat pack. Nat Med 2010, 16:254-257.
51. Birnbaum D.J., Adelaide J., Mamessier E., Finetti P., Lagarde A., Monges G., et al. Genome profiling of pancreatic adenocarcinoma. Genes Chromosomes Cancer 2011, 50:456-465.
52. Dusetti N.J., Tomasini R., Azizi A., Barthet M., Vaccaro M.I., Fiedler F., et al. Expression profiling in pancreas during the acute phase of pancreatitis using cDNA microarrays. Biochem Biophys Res Commun 2000, 277:660-667.
53. Friess H., Ding J., Kleeff J., Liao Q., Berberat P.O., Hammer J., et al. Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 2001, 234:769-778. [discussion 78-9].